UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________SCHEDULE 14AProxy Statement Pursuant to...
0001689657 false 0001689657 2023-04-06 2023-04-06 iso4217:USD xbrli:shares...
PhenomeX to Participate in American Association of Cancer Research Annual Meeting 2023 PR Newswire EMERYVILLE...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No...
Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company PR...
Filed Pursuant to Rule 424(b)(3) Registration No. 333-269466 SUPPLEMENT NO. 3, DATED March 9, 2023...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13d - 102) INFORMATION TO BE...
Filed Pursuant to Rule 424(b)(3) Registration No. 333-269466 SUPPLEMENT NO. 2, DATED MARCH 2, 2023 (to the Joint...
As filed with the Securities and Exchange Commission on February 27, 2023 Registration No. 333- ...
00016896572022FYfalse50http://fasb.org/us-gaap/2022#RevenueFromContractWithCustomerExcludingAssessedTaxhttp://fa...
FALSE000168965700016896572023-02-232023-02-23UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Form 8-KCURRENT REPORTPursuant...
Berkeley Lights Reports Fourth Quarter and Full Year 2022 Financial Results PR Newswire EMERYVILLE, Calif...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.